Sutro Biopharma (STRO) Other Working Capital Changes (2017 - 2025)

Sutro Biopharma has reported Other Working Capital Changes for 8 years, with the latest figure at -$145000.0 in Q4 2025.

• Quarterly Other Working Capital Changes rose 98.24% year-over-year to -$145000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$69.7 million (down 988.83% YoY) and the FY2025 annual result came in at -$69.7 million, down 988.83% from the prior year.
• Other Working Capital Changes climbed to -$145000.0 in Q4 2025 per STRO's latest filing, from -$6.1 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $7.4 million in Q1 2023 and troughed at -$8.0 million in Q3 2025.
• A 5-year average of -$19900.0 and a median of $141000.0 in 2022 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes soared 3860.29% in 2022, then slumped 3076.55% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$2.5 million in 2021, then jumped by 3860.29% to $92.2 million in 2022, then slumped by 130.46% to -$28.1 million in 2023, then jumped by 70.67% to -$8.2 million in 2024, then soared by 98.24% to -$145000.0 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$145000.0, -$6.1 million, and -$61.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.